公开(公告)号：US20230277583A1

公开(公告)日：2023-09-07

申请号：US18179069

申请日：2023-03-06

申请人： Augusta University Research Institute, Inc. ,  Hillhurst Biopharmaceuticals, Inc.

发明人： Pamela Martin ,  Ravirajsinh Jadeja ,  Andrew Gomperts

IPC分类号： A61K33/00 ,  A61P27/02 ,  A61P3/10

CPC分类号： A61K33/00 ,  A61P27/02 ,  A61P3/10

摘要： Enteral formulations containing including therapeutically effective amount carbon monoxide, and methods of use thereof, for treatment of ocular diseases and disorders are provided. The formulations can be administered in a subject in need thereof in an effective amount to reduce or prevent an ocular disease in the subject, and thus reduce one or more symptoms of disease, disorder, or illness associated with the disease. In some embodiments, the formulation is administered orally.